 NEW YORK, Jan. 08, 2021 GLOBE NEWSWIRE -- Daxor Corporation NYSE MKT: DXR, the global leader in blood volume measurement technology organized as an investment company with fully-owned innovative medical instrumentation and biotechnology operations, today announces that Michael Feldschuh, Daxors President Chief Executive Officer, will present at the inaugural H.C. Wainwright BioConnect Investment Conference which is being held from January 11th to 14th through a virtual format with on-demand video presentations. 